The Pennant Group (NASDAQ:PNTG – Get Free Report) updated its FY 2024 earnings guidance on Tuesday. The company provided earnings per share (EPS) guidance of 0.890-0.950 for the period, compared to the consensus estimate of 0.890. The company issued revenue guidance of $654.0 million-$694.5 million, compared to the consensus revenue estimate of $633.2 million.
Analyst Ratings Changes
A number of brokerages have recently commented on PNTG. Stephens upped their price objective on shares of The Pennant Group from $28.00 to $32.00 and gave the company an overweight rating in a research report on Thursday. Royal Bank of Canada upped their price objective on shares of The Pennant Group from $21.00 to $26.00 and gave the company an outperform rating in a research report on Thursday, May 9th. Oppenheimer upped their price objective on shares of The Pennant Group from $28.00 to $34.00 and gave the company an outperform rating in a research report on Thursday. Finally, Truist Financial upped their price objective on shares of The Pennant Group from $25.00 to $28.00 and gave the company a hold rating in a research report on Monday, July 15th.
Read Our Latest Analysis on The Pennant Group
The Pennant Group Price Performance
The Pennant Group (NASDAQ:PNTG – Get Free Report) last released its quarterly earnings results on Monday, May 6th. The company reported $0.15 EPS for the quarter, meeting the consensus estimate of $0.15. The Pennant Group had a net margin of 2.86% and a return on equity of 13.42%. The business had revenue of $156.92 million for the quarter, compared to analysts’ expectations of $146.01 million. Equities research analysts expect that The Pennant Group will post 0.73 EPS for the current fiscal year.
The Pennant Group Company Profile
The Pennant Group, Inc provides healthcare services in the United States. It operates in two segments, Home Health and Hospice Services, and Senior Living Services. The company offers home health services, including clinical services, such as nursing, speech, occupational and physical therapy, medical social work, and home health aide services; and hospice services comprising clinical care, education, and counseling services for the physical, spiritual, and psychosocial needs of terminally ill patients and their families.
See Also
- Five stocks we like better than The Pennant Group
- 3 Grocery Stocks That Can Help Take a Bite Out of Inflation
- Owens-Corning Stock: Good Value or Recession Red Flag?
- Asset Allocation: The Key to a Successful Portfolio. Are You Paying Attention to Yours?
- Datadog Exceeds Q2 Expectations, Solidifies Market Leadership
- How to Use High Beta Stocks to Maximize Your Investing Profits
- Cybersecurity Stock Surges, Promising Double-Digit Gains
Receive News & Ratings for The Pennant Group Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for The Pennant Group and related companies with MarketBeat.com's FREE daily email newsletter.